Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma: an Open-label, Randomised, Prospective Study

NCT05654896 is registered in ClinicalTrials.gov with Nadeem Iqbal as lead sponsor.

NCT NCT05654896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05654896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma: an Open-label, Randomised, Prospective Study
Lead sponsor
Nadeem Iqbal
Phase
Phase 3
Overall status
Unknown status
Start date
November 26, 2022
Completion date
December 26, 2023
Enrollment
158 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic prophylaxis